ClinicalTrials.gg
CompletedNCT05356208Updated Mar 29, 2023

Long-term Outcome After Cleft-lift for Pilonidal Sinus Disease

An observational study in Pilonidal Sinus, sponsored by Nordsjaellands Hospital. Completed at 1 site in Denmark. Open to participants aged 14 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-03-29.

Sponsored by Nordsjaellands Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
224
Ages
14 Years to 99 Years
Sex
All
01

Study summary

Single-center cohort study of 10-year risk of treatment failure after cleft-lift under tumescent local analgesia for pilonidal sinus disease

Read the detailed description

The standard treatment at Nordsjællands Hospital in Hillerød (NOH) has since 2007 been Bascom's pit-pick procedure (PP) for simple pilonidal sinus disease (PSD), while Bascom's cleft-lift procedure (CL)has been performed in complicated cases not suitable for PP operation, recurrences following previous excisions, including PP, and unhealed midline wounds.

CL has mainly been performed under tumescent local analgesia (TLA) in a day-surgery setting. TLA is well tolerated with high patient satisfaction and acceptable short-term outcomes. TLA provides a potentially higher cost-effectiveness not requiring presence of an anesthesiologist, shorter duration of the complete procedure and elimination of the risks and discomforts associated with general anesthetics.

The study is based on data of patients in a local pilonidal database. The patients in the database have all undergone surgery for pilonidal sinus disease at NOH during the period of 2007 to 2014. Data in the database has been collected prospectively up to one year following surgery and subsequently supplemented with data collected by questionnaire and telephone interviews for the period from one year follow-up and until the date of long-term follow-up. Study data were collected and managed using REDCap electronic data capture tools hosted at NOH.

Patients receive a REDCap survey per e-mail to a personal digital mailbox or are asked to participate in a telephone interview to fill out a standardized questionnaire. Patients without a personal digital mailbox receive the questionnaire by regular mail. The survey is sent out twice with a four-week interval. Only patients who do not fill out the questionnaire the first time, receive the survey a second time as a reminder. Telephone interviews are only conducted, if patients do not reply to the questionnaire received digitally or as a physical copy. The questionnaire includes questions regarding demographic characteristics, lifestyle, complications, recurrence and new interventions, pain, and cosmetic satisfaction. Medical records are reviewed to verify answers from the questionnaire if consent by the patient is given through the survey or during the telephone interview. Patients experiencing symptoms of recurrence, are offered an assessment at the hospital.

The procedure has been described previously and performed with minor modifications of the original description by John Bascom. All procedures were performed in a day-surgical setting. With the patient in the prone position, the natal cleft was opened and exposed by retraction with elastic bandage tape before the sterile surgical draping was applied. The resection area and a flap on the less affected side were outlined with the intention of 2-3 cm lateralization of the wound. A hockey incision was outlined in the distal part of the excision to achieve lateralization at the distal end of the wound. Subcutaneous TLA with a modified Klein's solution containing mepivacaine 0.8 mg/mL, adrenaline 1 µg/mL, and sodium bicarbonate 42 µg/mL in isotonic saline water was infused through a 2-inch 21-gauge needle under a pressure of approximately 300 mm hg using a pressure infusion bag. If fibrous tissue affected the subcutaneous tissue, the solution was infiltrated by a 20-ml syringe. In case of pain during surgery, a supplementary tumescent solution was administered. If acceptable analgesia could not be obtained, intravenous sedation or analgesia was administrated at the patient's request.

A flap with a thickness of approximately 7 mm was mobilized to the marked outer line to ensure tension-free tissue coverage of the excision. All primary pits in the midline were excised en-bloc, and all hair and granulation tissue in the subcutis was removed with a surgical swap or by curettage, saving as much fibrotic tissue as possible to provide padding. The retraction tape was released, and the surgical wound was closed with absorbable monofilament multilayer sutures subcutaneously with the intention of reducing any dead space in the subcutis before intracutaneous closure with polypropylene or monofilament short-term absorbable suture. A 10-French drain with no vacuum or silicon ribbon drains was placed under the flap. The wound was reinforced with strips and covered by a hydrofiber bandage. All patients received one dose of cefuroxime 1.5 g and metronidazole 1.0 g intravenously preoperatively, and cephalexin 500 mg and metronidazole 500 mg orally three times daily for three days as prophylaxis.

Risk of recurrence is analyzed using competing risk analysis as well as univariate and multivariate Cox regression analyses including the following risk factors: sex, age, smoking, BMI, relevant co-morbidities, diabetes mellitus, acne, hidradenitis, previous interventions, preoperative abscess, number of primary and secondary pits, number of lateral incisions and postoperative complications. Time to complete wound healing is analyzed by Kaplan-Meier plots. Remaining outcomes are analyzed as categorical variables using descriptive data analyses.

02

Conditions studied

  • Pilonidal Sinus

Browse trials for

Keywords

  • Cleft-lift
  • Tumescent local analgesia
03

In context

Pilonidal Sinus

109 studies on the registry are indexed under Pilonidal Sinus; 32 are open to participants now.

This study's enrollment of 224 is above the median of 145 across 37 observational studies indexed under Pilonidal Sinus.

Browse Pilonidal Sinus studies →

Lead sponsor

Nordsjaellands Hospital is the lead sponsor of 89 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with moderate to complex pilonidal sinus disease referred to a secondary and tertiary care hospital. Patients with history of surgery for pilonidal sinus disease are included in the cohort.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergoing pit-pick at Nordsjællands Hospital during the study period

Exclusion criteria

Exclusion Criteria:

  • Non-Danish residents
  • Patients planned for general anesthesia were excluded
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
224 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Treatment failure assessed by clinical assessment or by questionnaire

    Incomplete wound healing or recurrence after complete wound healing

    Time frame: 10 years

Secondary outcomes

  1. Chronic pain related to cicatrix

    Numerical rate scale pain score (0-10). 0 being no pain and 10 being the the worst

    Time frame: 10 years

  2. Cosmetic appearance of the cicatrix

    Numerical rate scale score (1-5). 1 being worst, 5 the better

    Time frame: 10 years

07

Study locations

1 site
  • Nordsjaellands Hospital
    Hillerød, 3400, Denmark
08

References and documents

Publications

  • Bertelsen CA. Cleft-lift operation for pilonidal sinuses under tumescent local anesthesia: a prospective cohort study of peri- and postoperative pain. Dis Colon Rectum. 2011 Jul;54(7):895-900. doi: 10.1007/DCR.0b013e31820ee852. PubMed 21654258 ↗
  • Svarre KJ, Serup CM, Kanstrup CTB, Kleif J, Bertelsen CA. Long-term outcome after Bascom's cleft-lift procedure under tumescent local analgesia for pilonidal sinus disease: a cohort study. Colorectal Dis. 2023 Apr;25(4):707-716. doi: 10.1111/codi.16420. Epub 2022 Nov 28. PubMed 36401803 ↗

Individual participant data

Plan to share: No — fter de-identification, individual participant data will be made available to investigators who provide a methodologically sound proposal for meta-analyses.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05356208
Lead sponsor
Nordsjaellands Hospital
Responsible party
Sponsor
First posted
May 2, 2022
Start date
Aug 1, 2007
Primary completion
May 31, 2021
Completion
May 31, 2021
Last update
Mar 29, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion